These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30537896)
41. Cardiac implantable electronic devices in patients with persistent left superior vena cava-A single center experience. Ghazzal B; Sabayon D; Kiani S; Leon AR; Delurgio D; Patel AM; Lloyd MS; Westerman S; Shah A; Merchant FM; El-Chami MF J Cardiovasc Electrophysiol; 2020 May; 31(5):1175-1181. PubMed ID: 32237003 [TBL] [Abstract][Full Text] [Related]
42. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Kirkfeldt RE; Johansen JB; Nohr EA; Jørgensen OD; Nielsen JC Eur Heart J; 2014 May; 35(18):1186-94. PubMed ID: 24347317 [TBL] [Abstract][Full Text] [Related]
43. Lead extraction: The road to successful cardiac resynchronization therapy. Maciąg A; Syska P; Sterliński M; Przybylski A; Sitkowska E; Oręziak A; Bilińska M; Kuśmierczyk M; Szwed H Cardiol J; 2015; 22(2):188-93. PubMed ID: 25299498 [TBL] [Abstract][Full Text] [Related]
44. Feasibility of concomitant implantation of permanent transvenous pacemaker and defibrillator systems. Blanck Z; Niazi I; Axtell K; Sra J; Jazayeri MR; Dhala A; Deshpande S; Akhtar M Am J Cardiol; 1994 Dec; 74(12):1249-53. PubMed ID: 7977099 [TBL] [Abstract][Full Text] [Related]
45. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627 [TBL] [Abstract][Full Text] [Related]
46. Prevalence of venous anatomic variants and occlusion among patients undergoing implantation of transvenous leads. Oginosawa Y; Abe H; Nakashima Y Pacing Clin Electrophysiol; 2005 May; 28(5):425-8. PubMed ID: 15869675 [TBL] [Abstract][Full Text] [Related]
47. Candidacy for a Subcutaneous Implantable Cardioverter Defibrillator in Patients with Cardiac Resynchronization Therapy. Kawabata M; Goya M; Takahashi Y; Maeda S; Yagishita A; Shirai Y; Kaneko M; Shiohira S; Hirao K Int Heart J; 2018 Sep; 59(5):951-958. PubMed ID: 30101850 [TBL] [Abstract][Full Text] [Related]
48. Cardiac implantable electronic device and vascular access: Strategies to overcome problems. Kusztal M; Nowak K J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930 [TBL] [Abstract][Full Text] [Related]
49. Long-term incidence of upper extremity venous obstruction in implantable cardioverter defibrillator patients. Horlbeck FW; Eckerth C; Linhart M; Schaefer C; Jakob M; Pingel S; Klarmann-Schulz U; Nickenig G; Schwab JO Pacing Clin Electrophysiol; 2021 Jun; 44(6):1027-1032. PubMed ID: 33974720 [TBL] [Abstract][Full Text] [Related]
50. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: A prospective serial venographic study. Korkeila P; Ylitalo A; Koistinen J; Airaksinen KE Ann Med; 2009; 41(3):216-23. PubMed ID: 18979290 [TBL] [Abstract][Full Text] [Related]
51. Unrecognized venous injuries after cardiac implantable electronic device transvenous lead extraction. Tarakji KG; Saliba W; Markabawi D; Rodriguez ER; Krauthammer Y; Brunner MP; Hussein AA; Baranowski B; Cantillon DJ; Kanj M; Niebauer M; Rickard J; Callahan T; Shao M; Martin DO; Wazni OM; Wilkoff BL; Tan CD Heart Rhythm; 2018 Mar; 15(3):318-325. PubMed ID: 29141184 [TBL] [Abstract][Full Text] [Related]
54. Percutaneous lead extraction and repositioning: An effective and safe therapeutic strategy for early ventricular lead perforation with dislocation both inside and outside the pericardial sac following a cardiac device implantation. Archontakis S; Sideris K; Aggeli K; Gatzoulis K; Demosthenous M; Tolios P; Lozos V; Koumallos N; Limperiadis D; Tousoulis D; Kallikazaros I; Sideris S J Cardiovasc Electrophysiol; 2019 Mar; 30(3):299-307. PubMed ID: 30516299 [TBL] [Abstract][Full Text] [Related]
55. Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections. Dhamija RK; Tan H; Philbin E; Mathew RO; Sidhu MS; Wang J; Saour B; Haqqie SS; Beathard G; Yevzlin AS; Salman L; Boden WE; Siskin G; Asif A Am J Kidney Dis; 2015 Jul; 66(1):154-8. PubMed ID: 25911316 [TBL] [Abstract][Full Text] [Related]
56. Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry. Sood N; Martin DT; Lampert R; Curtis JP; Parzynski C; Clancy J Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e004768. PubMed ID: 29453324 [TBL] [Abstract][Full Text] [Related]
57. Ultrasound-guided axillary venous access for pediatric and adult congenital lead implantation. Clark BC; Janson CM; Nappo L; Pass RH Pacing Clin Electrophysiol; 2019 Feb; 42(2):166-170. PubMed ID: 30515865 [TBL] [Abstract][Full Text] [Related]
58. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations. Kosiuk J; Koutalas E; Doering M; Sommer P; Rolf S; Breithardt OA; Nedios S; Dinov B; Hindricks G; Richter S; Bollmann A Europace; 2014 Jul; 16(7):1028-32. PubMed ID: 24489073 [TBL] [Abstract][Full Text] [Related]
59. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Klug D; Balde M; Pavin D; Hidden-Lucet F; Clementy J; Sadoul N; Rey JL; Lande G; Lazarus A; Victor J; Barnay C; Grandbastien B; Kacet S; Circulation; 2007 Sep; 116(12):1349-55. PubMed ID: 17724263 [TBL] [Abstract][Full Text] [Related]
60. Lead Extraction With Baffle Stenting in Adults With Transposition of the Great Arteries. Laredo M; Waldmann V; Chaix MA; Ibrahim R; Casteigt B; Dubuc M; Thibault B; Asgar AW; Dore A; Mongeon FP; Khairy P; Mondésert B JACC Clin Electrophysiol; 2019 Jun; 5(6):671-680. PubMed ID: 31221353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]